Annual Current Liabilities
$29.82 M
+$12.52 M+72.32%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual total current liabilities is $29.82 million, with the most recent change of +$12.52 million (+72.32%) on December 31, 2023.
- During the last 3 years, TCRX annual current liabilities has risen by +$12.37 million (+70.93%).
- TCRX annual current liabilities is now at all-time high.
Performance
TCRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$28.66 M
-$9.91 M-25.70%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly total current liabilities is $28.66 million, with the most recent change of -$9.91 million (-25.70%) on September 30, 2024.
- Over the past year, TCRX quarterly current liabilities has dropped by -$4.49 million (-13.55%).
- TCRX quarterly current liabilities is now -25.70% below its all-time high of $38.57 million, reached on June 30, 2024.
Performance
TCRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TCRX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +72.3% | -13.6% |
| 3 y3 years | +70.9% | -13.6% |
| 5 y5 years | +1144.6% | -13.6% |
TCRX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +72.3% | -25.7% | +104.0% |
| 5 y | 5-year | at high | +1144.6% | -25.7% | +104.0% |
| alltime | all time | at high | +1144.6% | -25.7% | +104.0% |
TScan Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $28.66 M(-25.7%) |
| Jun 2024 | - | $38.57 M(+22.5%) |
| Mar 2024 | - | $31.48 M(+5.6%) |
| Dec 2023 | $29.82 M(+72.3%) | $29.82 M(-10.0%) |
| Sep 2023 | - | $33.15 M(-5.6%) |
| Jun 2023 | - | $35.12 M(+150.0%) |
| Mar 2023 | - | $14.05 M(-18.8%) |
| Dec 2022 | $17.30 M | $17.30 M(+4.3%) |
| Sep 2022 | - | $16.59 M(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $17.17 M(-7.0%) |
| Mar 2022 | - | $18.46 M(-13.5%) |
| Dec 2021 | $21.34 M(+22.3%) | $21.34 M(-7.0%) |
| Sep 2021 | - | $22.94 M(+11.3%) |
| Jun 2021 | - | $20.62 M(+9.4%) |
| Mar 2021 | - | $18.84 M(+8.0%) |
| Dec 2020 | $17.45 M(+628.1%) | - |
| Dec 2020 | - | $17.45 M |
| Dec 2019 | $2.40 M | - |
FAQ
- What is TScan Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for TScan Therapeutics?
- What is TScan Therapeutics annual current liabilities year-on-year change?
- What is TScan Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for TScan Therapeutics?
- What is TScan Therapeutics quarterly current liabilities year-on-year change?
What is TScan Therapeutics annual total current liabilities?
The current annual current liabilities of TCRX is $29.82 M
What is the all time high annual current liabilities for TScan Therapeutics?
TScan Therapeutics all-time high annual total current liabilities is $29.82 M
What is TScan Therapeutics annual current liabilities year-on-year change?
Over the past year, TCRX annual total current liabilities has changed by +$12.52 M (+72.32%)
What is TScan Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TCRX is $28.66 M
What is the all time high quarterly current liabilities for TScan Therapeutics?
TScan Therapeutics all-time high quarterly total current liabilities is $38.57 M
What is TScan Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TCRX quarterly total current liabilities has changed by -$4.49 M (-13.55%)